Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00365833 · ClinicalTrials.gov registry record
CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 8
- Enrollment target
NCT00365833: Clinical Trial study, sponsored by University of Florida.
NCT00365833 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00365833 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
We believe that certain cells in the human body (Circulating Endothelial Cells and Endothelial Progenitor Cells) are related to risk of cardiovascular disease. It may be possible to measure levels of these cells in patients who have had a kidney transplant and predict their risk of developing cardiovascular disease.
Primary Outcome
Cardiovascular Risk Profile is defined by calculated Framingham Model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-02 |
Why NCT00365833 stopped before completion
NCT00365833 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00365833 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00365833 about?
NCT00365833 is a clinical study titled "CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients". We believe that certain cells in the human body (Circulating Endothelial Cells and Endothelial Progenitor Cells) are related to risk of cardiovascular disease. It may be possible to measure levels of these cells in patients who have had a kidney transplant and predict their risk of developing cardio...
What is the current status of trial NCT00365833?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2006-07. Estimated completion is 2007-02.
Who is sponsoring clinical trial NCT00365833?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia